Trial · NCT05385744
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Annualized relapse rate | week 48 | Annualized relapse rate at 48 weeks after the randomization of the last patient in the study |
| Secondary | Proportion of patients with persistent progression | week 48 | Persistent progression is defined as an increase in the EDSS score from Visit 1 by at least 1.0 in patients with a score \>0 and ≤5.5 at the first visit and by at least 1.5 in patients with a score of 0 at the first visit |
| Secondary | Total number of T1 Gd+ lesions | week 48 | Total number of T1 Gd+ lesions (per scan) detected on brain MRI; |
| Secondary | CUA | week 48 | Combined unique active lesions |
| Secondary | Proportion of patients without contrast-enhancing lesions | week 48 | Proportion of patients without contrast-enhancing lesions |
| Secondary | Number of new or enlarged T2 lesions | week 48 | Number of new or enlarged T2 lesions |
| Secondary | Proportion of patients without new or enlarged T2 lesions | week 48 | Proportion of patients without new or enlarged T2 lesions |
| Secondary | Changes in the neurologic deficit according to EDSS score | week 48 | Changes in the neurologic deficit according to Expanded Disability Status Scale |
| Secondary | Annualized relapse rate | week 48 | Mean annualized relapse rate |
| Secondary | Proportion of patients with adverse reactions | week 48 | |
| Secondary | Proportion of patients with serious adverse reactions | week 48 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05385744/registered